TabletsDouble-Blind MethodMigraine DisordersAspirinPlacebosMigraine with AuraMigraine without AuraTreatment OutcomeTablets, Enteric-CoatedPlacebo EffectChemistry, PharmaceuticalExcipientsAnti-Inflammatory Agents, Non-SteroidalTryptaminesPlatelet Aggregation InhibitorsDelayed-Action PreparationsDrug CompoundingHeadacheCross-Over StudiesHeadache DisordersAdministration, OralTechnology, PharmaceuticalSumatriptanTension-Type HeadacheMethylcellulosePowdersDrug Therapy, CombinationSolubilityPhotophobiaCortical Spreading DepressionTiclopidineErgotamineHardnessThromboxane B2DihydroergotamineAnalgesicsCyclooxygenase InhibitorsDose-Response Relationship, DrugCapsulesPlatelet AggregationTime FactorsDosage FormsAcetaminophenSalicylatesPizotylineSerotonin Receptor AgonistsTherapeutic EquivalencyNaproxenIbuprofenLubricantsRandomized Controlled Trials as TopicDrug Administration ScheduleDrug CombinationsProspective StudiesPlatelet Function TestsClinical Trials as TopicBiological AvailabilityPain MeasurementAnalgesics, Non-NarcoticCellulosePovidoneDrug StabilityAdministration, BuccalRisk FactorsHardness TestsSingle-Blind MethodBlood PlateletsFollow-Up StudiesHeadache Disorders, PrimaryHeadache Disorders, SecondaryOphthalmoplegic MigraineRecurrenceFibrinolytic AgentsHemorrhageSodium SalicylateAdministration, SublingualMetoclopramideSuspensionsAnticoagulantsHyperacusisCarboxymethylcellulose SodiumCompressive StrengthStrokeEtodolacPainChronic DiseaseForamen Ovale, PatentCalcitonin Gene-Related PeptideQuestionnairesWarfarinDrug InteractionsAsthma, Aspirin-InducedCyclooxygenase 2 InhibitorsDiclofenacFamotidinePolymethacrylic AcidsSeverity of Illness IndexCase-Control StudiesGastrointestinal HemorrhageCyclooxygenase 1